enobosarm
enobosarm: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| VERU INC. (VERU) | Phase 3 |
Clinical Trials (1)
PLATEAU: Phase 2b Proof-of-Concept Study to Evaluate the Effect on Total Body Weight, Physical Function and Safety of Enobosarm in Patients Treated With Semaglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, for Weight Reduction
Frequently asked questions
Who is developing enobosarm?
enobosarm is being developed by VERU INC..
How many clinical trials involve enobosarm?
BioSniper tracks 1 clinical trial involving enobosarm.
Get deeper analysis on enobosarm
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis